Artemisin

Artemisin

SCHEMBL60303

C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 9/20 1.00
ALDH1A1 P00352 4/20 1.00
LMNA P02545 3/20 1.00
HTT P42858 3/20 1.00
CYP1A2 P05177 2/20 1.00
CYP3A4 P08684 2/20 1.00
CYP2D6 P10635 1/20 1.00
CYP2C19 P33261 1/20 1.00
HIF1A Q16665 1/20 1.00
NR1I2 O75469 1/20 1.00
CYP2B6 P20813 1/20 1.00
GAA P10253 1/20 1.00
HPGD P15428 1/20 1.00
HSD17B10 Q99714 1/20 1.00
TP53 P04637 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Artemisin SCHEMBL19600819 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisinin SCHEMBL60304 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL11959711 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL7071338 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL23843508 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL13428542 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL23974927 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL16587860 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL16587369 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2
Artemisin SCHEMBL9884398 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 22350 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121378801-B Photo-crosslinking double-network hydrogel for promoting skin wound healing and preparation method thereof Shandong second people's Hospital (Shandong ear nose throat hospital, Shandong ear nose throat Research Institute) (CN) 2026-05-26 CN claimed
CN-122075580-A Mixture of sweet wormwood herb extract and rosemary extract, preparation method and application 2026-05-26 CN claimed
CN-122075438-A Synergistic anticancer application of redox responsive coacervate delivery chrysin and 3-methyladenine 2026-05-26 CN claimed
CN-122070916-A Application of arteannuin with double functions in promoting liver cell maturation and relieving liver lipid metabolism dysfunction 广州市第一人民医院(广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院) 2026-05-22 CN claimed
CN-224241781-U Heat preservation device for extracting artemisinin 云南群优生物科技有限公司 2026-05-15 CN claimed
US-20260130966-A1 NOVEL THERAPEUTICS FOR PARASITIC INFECTION UNIV SOUTH FLORIDA (US) 2026-05-14 US claimed
US-20260130918-A1 TRANSCRIPTION FACTOR PFAP2-O5 INHIBITOR FOR PLASMODIUM FALCIPARUM, PHARMACEUTICAL COMPOSITION, AND DRUG FOR TREATING MALARIA RESISTANT TO ARTEMISININ AND ANALOG THEREOF TONGJI UNIVERSITY (CN) 2026-05-14 US claimed
EP-4739299-A1 MODELS OF CONE PHOTORECEPTOR DEGENERATION SORBONNE UNIVERSITE (FR) 2026-05-13 EP claimed
CN-116355953-B Plant expression vector for improving artemisinin content in sweet wormwood herb, recombinant transformant, sweet wormwood herb and application thereof 上海交通大学 2026-05-12 CN claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
CN-1045509-A Insecticides containing \" chazaosu \" plant material TEACHER TRAINING UNIV OF HUNAN (CN) 1990-09-26 CN claimed
US-4952603-A Method for the isolation of artemisinin from Artemisia annua UNIVERSITY OF MISSISSIPPI 1990-08-28 US claimed
CN-1041694-A The anti-malaria composition of quinidine, arteannuin and derivant thereof and Therapeutic Method HOECHST AG (DE) 1990-05-02 CN claimed
EP-0346356-A1 SYNTHESIS PROCESS AND OXYGEN-CONTAINING HETEROCYCLIC PRODUCTS THEREOF SRI INTERNATIONAL (US) 1989-12-20 EP claimed
EP-0290959-A2 Drug mixture for prophylaxis and therapy of malaria HOECHST AKTIENGESELLSCHAFT (DE) 1988-11-17 EP claimed
CN-85100781-B Preparation method of artesunate as antimalarial 广西壮族自治区桂林制药厂 1988-07-06 CN claimed
WO-1988004660-A2 SYNTHESIS PROCESS AND OXYGEN-CONTAINING HETEROCYCLIC PRODUCTS THEREOF SRI INTERNATIONAL (US) 1988-06-30 WO claimed
CN-87101346-A EXTRACTION TECHNOLOGY FOR ARTEMISIA ANNUA ELEMENT 1988-03-09 CN claimed
CN-85100781-A Antimalerian drug-ester of artemisinin and preparation method thereof 1986-08-20 CN claimed
CN-85100978-A The production technology of dihydroartemisinine 1986-08-13 CN claimed